Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2EV study. - Fiala O; Buti S; Fujita K; de Liaño AG; Fukuokaya W; Kimura T; Yanagisawa T; Giannatempo P; Angel M; Mennitto A; Molina-Cerrillo J; Bourlon MT; et al. (Clinical & experimental metastasis, 2025)